Advertisement

Reactions Weekly

, Volume 1719, Issue 1, pp 9–9 | Cite as

Infection-related costs higher with dasatinib than nilotinib

Clinical study
  • 14 Downloads

Reference

  1. Seiter K, et al. Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States. Advances in Therapy : 28 Aug 2018. Available from: URL: http://doi.org/10.1007/s12325-018-0772-3

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations